CIK 0000925741
- Non-accelerated filer
- Smaller reporting company
BioCardia, Inc.
Sign in to watch- Ticker
- BCDA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 232753988
- Phone
- +1 650-226-0123
- Business address
- 320 SOQUEL WAY, SUNNYVALE, CA, 94085
- Former names
- Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP
- Open-market buys, last 90 days
- $4,372
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$4,372. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-06 | McClung David Chief Financial Officer | Grant or award · Stock Option (right to buy) | +41,501 | 87,841 | ||
| 2026-07-02 | McClung David Chief Financial Officer | Shares withheld for taxes | −23,125 | $1.24 | $29K | 114,245 |
| 2026-06-29 | McClung David Chief Financial Officer | Grant or award | +60,483 | $1.20 | $73K | 137,370 |
| 2025-12-08 | McClung David Chief Financial Officer | Grant or award | +58,276 | $1.37 | $80K | 106,226 |
| 2025-12-08 | McClung David Chief Financial Officer | Shares withheld for taxes | +29,339 | $1.37 | $40K | 76,887 |
| 2025-12-08 | McClung David Chief Financial Officer | Grant or award · Stock Option (right to buy) | +27,000 | 46,340 | ||
| 2025-06-30 | McClung David Chief Financial Officer | Purchase | +4,819 | $2.08 | $10K | 47,950 |
| 2025-06-30 | McClung David Chief Financial Officer | Purchase · Warrant (right to buy) | +4,819 | 26,275 | ||
| 2025-04-23 | McClung David Chief Financial Officer | Purchase | +13,123 | $1.91 | $25K | 43,131 |
| 2025-04-23 | McClung David Chief Financial Officer | Purchase · Warrant (right to buy) | +13,123 | 21,456 | ||
| 2024-10-11 | McClung David Chief Financial Officer | Grant or award | +24,193 | $2.65 | $64K | 41,573 |
| 2024-10-11 | McClung David Chief Financial Officer | Shares withheld for taxes | −11,565 | $2.65 | $31K | 30,008 |
| 2024-09-03 | McClung David Chief Financial Officer | Grant or award | +8,333 | $3.00 | $25K | 17,380 |
| 2024-09-03 | McClung David Chief Financial Officer | Grant or award · Warrant (right to buy) | +8,333 | 8,333 | ||
| 2023-06-23 | McClung David Chief Financial Officer | Grant or award | +4,280 | $2.34 | $10K | 135,724 |
| 2023-05-31 | McClung David Chief Financial Officer | Shares withheld for taxes | −20,676 | $1.77 | $37K | 131,444 |
| 2023-05-18 | McClung David Chief Financial Officer | Grant or award | +61,389 | $1.70 | $104K | 152,120 |
| 2023-05-18 | McClung David Chief Financial Officer | Grant or award · Stock Option (right to buy) | +68,265 | 68,265 | ||
| 2022-12-16 | McClung David Chief Financial Officer | Grant or award | +8,928 | $1.68 | $15K | 87,446 |
| 2022-10-10 | McClung David Chief Financial Officer | Purchase | +2,000 | $2.07 | $4K | 78,518 |
Page 1 of 3 · 43 trades